Prevymis (letermovir) - Merck (MSD)
Letermovir prophylaxis in pediatric haploidentical TCR αβ-depleted transplants: real-world outcomes in a low and middle-income country. (PubMed, Bone Marrow Transplant) - Jul 14, 2026 - No abstract available 
Journal • Real-world evidence • Pediatrics • Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/42443468
 
Ajmeera A Azeez; Niveditha S Reddy; Pavithra Balakrishnan; Pooja P Mallya; Shobha Badiger; Shreyas A C; Sunil Bhat
 
Jul 14, 2026
 
Prev Next